Implantable Insulin Pumps Market Size to Hit USD 14.27 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Implantable Insulin Pumps Market, By Pump Type

7.1. Implantable Insulin Pumps Market Revenue and Volume, by Pump Type

7.1.1. Programmable Implantable Pumps

7.1.1.1. Market Revenue and Volume Forecast

7.1.2. Closed-loop Pumps

7.1.2.1. Market Revenue and Volume Forecast

7.1.3. Open-loop Pumps

7.1.3.1. Market Revenue and Volume Forecast

7.1.4. Non-programmable Implantable Pumps

7.1.4.1. Market Revenue and Volume Forecast

7.1.5. Others (Hybrid Delivery Systems)

7.1.5.1. Market Revenue and Volume Forecast

Chapter 8. Global Implantable Insulin Pumps Market, By Reservoir Size

8.1. Implantable Insulin Pumps Market Revenue and Volume, by Reservoir Size

8.1.1. Small Volume (≤10 mL)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Medium Volume (10–20 mL)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Large Volume (>20 mL)

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Implantable Insulin Pumps Market, By Delivery Mode

9.1. Implantable Insulin Pumps Market Revenue and Volume, by Delivery Mode

9.1.1. Continuous Basal Delivery

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Bolus Delivery

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Combined Basal-Bolus Delivery

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Implantable Insulin Pumps Market, By End User

10.1. Implantable Insulin Pumps Market Revenue and Volume, by End User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Ambulatory Surgical Centers (ASCs)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Specialty Diabetes Clinics

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Homecare Settings

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others (Military, Research)

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Implantable Insulin Pumps Market, By Age Group

11.1. Implantable Insulin Pumps Market Revenue and Volume, by Age Group

11.1.1. Pediatric (≤17 years)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Adults (18–64 years)

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Geriatric (≥65 years)

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Implantable Insulin Pumps Market, By Indication

12.1. Implantable Insulin Pumps Market Revenue and Volume, by Indication

12.1.1. Type 1 Diabetes Mellitus (T1DM)

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Type 2 Diabetes Mellitus (T2DM)

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Others (e.g., LADA, MODY)

12.1.3.1. Market Revenue and Volume Forecast

Chapter 13. Global Implantable Insulin Pumps Market, By Distribution Channel

13.1. Implantable Insulin Pumps Market Revenue and Volume, by Distribution Channel

13.1.1. Direct Hospital Procurement

13.1.1.1. Market Revenue and Volume Forecast

13.1.2. Retail Pharmacies

13.1.2.1. Market Revenue and Volume Forecast

13.1.3. Online Pharmacies

13.1.3.1. Market Revenue and Volume Forecast

13.1.4. Others

13.1.4.1. Market Revenue and Volume Forecast

Chapter 14. Global Implantable Insulin Pumps Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Pump Type

14.1.2. Market Revenue and Volume Forecast, by Reservoir Size

14.1.3. Market Revenue and Volume Forecast, by Delivery Mode

14.1.4. Market Revenue and Volume Forecast, by End User

14.1.5. Market Revenue and Volume Forecast, by Age Group

14.1.6. Market Revenue and Volume Forecast, by Distribution Channel

14.1.7. Market Revenue and Volume Forecast, by Indication

14.1.8. U.S.

14.1.8.1. Market Revenue and Volume Forecast, by Pump Type

14.1.8.2. Market Revenue and Volume Forecast, by Reservoir Size

14.1.8.3. Market Revenue and Volume Forecast, by Delivery Mode

14.1.8.4. Market Revenue and Volume Forecast, by End User

14.1.8.5. Market Revenue and Volume Forecast, by Age Group

14.1.8.6. Market Revenue and Volume Forecast, by Distribution Channel

14.1.8.7. Market Revenue and Volume Forecast, by Indication

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Pump Type

14.1.9.2. Market Revenue and Volume Forecast, by Reservoir Size

14.1.9.3. Market Revenue and Volume Forecast, by Delivery Mode

14.1.9.4. Market Revenue and Volume Forecast, by End User

14.1.9.5. Market Revenue and Volume Forecast, by Age Group

14.1.9.6. Market Revenue and Volume Forecast, by Distribution Channel

14.1.9.7. Market Revenue and Volume Forecast, by Indication

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Pump Type

14.2.2. Market Revenue and Volume Forecast, by Reservoir Size

14.2.3. Market Revenue and Volume Forecast, by Delivery Mode

14.2.4. Market Revenue and Volume Forecast, by End User

14.2.5. Market Revenue and Volume Forecast, by Age Group

14.2.6. Market Revenue and Volume Forecast, by Distribution Channel

14.2.7. Market Revenue and Volume Forecast, by Indication

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Pump Type

14.2.8.2. Market Revenue and Volume Forecast, by Reservoir Size

14.2.8.3. Market Revenue and Volume Forecast, by Delivery Mode

14.2.8.4. Market Revenue and Volume Forecast, by End User

14.2.8.5. Market Revenue and Volume Forecast, by Age Group

14.2.8.6. Market Revenue and Volume Forecast, by Distribution Channel

14.2.8.7. Market Revenue and Volume Forecast, by Indication

14.2.9. Germany

14.2.9.1. Market Revenue and Volume Forecast, by Pump Type

14.2.9.2. Market Revenue and Volume Forecast, by Reservoir Size

14.2.9.3. Market Revenue and Volume Forecast, by Delivery Mode

14.2.9.4. Market Revenue and Volume Forecast, by End User

14.2.9.5. Market Revenue and Volume Forecast, by Age Group

14.2.9.6. Market Revenue and Volume Forecast, by Distribution Channel

14.2.9.7. Market Revenue and Volume Forecast, by Indication

14.2.10. France

14.2.10.1. Market Revenue and Volume Forecast, by Pump Type

14.2.10.2. Market Revenue and Volume Forecast, by Reservoir Size

14.2.10.3. Market Revenue and Volume Forecast, by Delivery Mode

14.2.10.4. Market Revenue and Volume Forecast, by End User

14.2.10.5. Market Revenue and Volume Forecast, by Age Group

14.2.10.6. Market Revenue and Volume Forecast, by Distribution Channel

14.2.10.7. Market Revenue and Volume Forecast, by Indication

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Volume Forecast, by Pump Type

14.2.11.2. Market Revenue and Volume Forecast, by Reservoir Size

14.2.11.3. Market Revenue and Volume Forecast, by Delivery Mode

14.2.11.4. Market Revenue and Volume Forecast, by End User

14.2.11.5. Market Revenue and Volume Forecast, by Age Group

14.2.11.6. Market Revenue and Volume Forecast, by Distribution Channel

14.2.11.7. Market Revenue and Volume Forecast, by Indication

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Pump Type

14.3.2. Market Revenue and Volume Forecast, by Reservoir Size

14.3.3. Market Revenue and Volume Forecast, by Delivery Mode

14.3.4. Market Revenue and Volume Forecast, by End User

14.3.5. Market Revenue and Volume Forecast, by Age Group

14.3.6. Market Revenue and Volume Forecast, by Distribution Channel

14.3.7. Market Revenue and Volume Forecast, by Indication

14.3.8. India

14.3.8.1. Market Revenue and Volume Forecast, by Pump Type

14.3.8.2. Market Revenue and Volume Forecast, by Reservoir Size

14.3.8.3. Market Revenue and Volume Forecast, by Delivery Mode

14.3.8.4. Market Revenue and Volume Forecast, by End User

14.3.8.5. Market Revenue and Volume Forecast, by Age Group

14.3.8.6. Market Revenue and Volume Forecast, by Distribution Channel

14.3.8.7. Market Revenue and Volume Forecast, by Indication

14.3.9. China

14.3.9.1. Market Revenue and Volume Forecast, by Pump Type

14.3.9.2. Market Revenue and Volume Forecast, by Reservoir Size

14.3.9.3. Market Revenue and Volume Forecast, by Delivery Mode

14.3.9.4. Market Revenue and Volume Forecast, by End User

14.3.9.5. Market Revenue and Volume Forecast, by Age Group

14.3.9.6. Market Revenue and Volume Forecast, by Distribution Channel

14.3.9.7. Market Revenue and Volume Forecast, by Indication

14.3.10. Japan

14.3.10.1. Market Revenue and Volume Forecast, by Pump Type

14.3.10.2. Market Revenue and Volume Forecast, by Reservoir Size

14.3.10.3. Market Revenue and Volume Forecast, by Delivery Mode

14.3.10.4. Market Revenue and Volume Forecast, by End User

14.3.10.5. Market Revenue and Volume Forecast, by Age Group

14.3.10.6. Market Revenue and Volume Forecast, by Distribution Channel

14.3.10.7. Market Revenue and Volume Forecast, by Indication

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Volume Forecast, by Pump Type

14.3.11.2. Market Revenue and Volume Forecast, by Reservoir Size

14.3.11.3. Market Revenue and Volume Forecast, by Delivery Mode

14.3.11.4. Market Revenue and Volume Forecast, by End User

14.3.11.5. Market Revenue and Volume Forecast, by Age Group

14.3.11.6. Market Revenue and Volume Forecast, by Distribution Channel

14.3.11.7. Market Revenue and Volume Forecast, by Indication

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Pump Type

14.4.2. Market Revenue and Volume Forecast, by Reservoir Size

14.4.3. Market Revenue and Volume Forecast, by Delivery Mode

14.4.4. Market Revenue and Volume Forecast, by End User

14.4.5. Market Revenue and Volume Forecast, by Age Group

14.4.6. Market Revenue and Volume Forecast, by Distribution Channel

14.4.7. Market Revenue and Volume Forecast, by Indication

14.4.8. GCC

14.4.8.1. Market Revenue and Volume Forecast, by Pump Type

14.4.8.2. Market Revenue and Volume Forecast, by Reservoir Size

14.4.8.3. Market Revenue and Volume Forecast, by Delivery Mode

14.4.8.4. Market Revenue and Volume Forecast, by End User

14.4.8.5. Market Revenue and Volume Forecast, by Age Group

14.4.8.6. Market Revenue and Volume Forecast, by Distribution Channel

14.4.8.7. Market Revenue and Volume Forecast, by Indication

14.4.9. North Africa

14.4.9.1. Market Revenue and Volume Forecast, by Pump Type

14.4.9.2. Market Revenue and Volume Forecast, by Reservoir Size

14.4.9.3. Market Revenue and Volume Forecast, by Delivery Mode

14.4.9.4. Market Revenue and Volume Forecast, by End User

14.4.9.5. Market Revenue and Volume Forecast, by Age Group

14.4.9.6. Market Revenue and Volume Forecast, by Distribution Channel

14.4.9.7. Market Revenue and Volume Forecast, by Indication

14.4.10. South Africa

14.4.10.1. Market Revenue and Volume Forecast, by Pump Type

14.4.10.2. Market Revenue and Volume Forecast, by Reservoir Size

14.4.10.3. Market Revenue and Volume Forecast, by Delivery Mode

14.4.10.4. Market Revenue and Volume Forecast, by End User

14.4.10.5. Market Revenue and Volume Forecast, by Age Group

14.4.10.6. Market Revenue and Volume Forecast, by Distribution Channel

14.4.10.7. Market Revenue and Volume Forecast, by Indication

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Volume Forecast, by Pump Type

14.4.11.2. Market Revenue and Volume Forecast, by Reservoir Size

14.4.11.3. Market Revenue and Volume Forecast, by Delivery Mode

14.4.11.4. Market Revenue and Volume Forecast, by End User

14.4.11.5. Market Revenue and Volume Forecast, by Age Group

14.4.11.6. Market Revenue and Volume Forecast, by Distribution Channel

14.4.11.7. Market Revenue and Volume Forecast, by Indication

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Pump Type

14.5.2. Market Revenue and Volume Forecast, by Reservoir Size

14.5.3. Market Revenue and Volume Forecast, by Delivery Mode

14.5.4. Market Revenue and Volume Forecast, by End User

14.5.5. Market Revenue and Volume Forecast, by Age Group

14.5.6. Market Revenue and Volume Forecast, by Distribution Channel

14.5.7. Market Revenue and Volume Forecast, by Indication

14.5.8. Brazil

14.5.8.1. Market Revenue and Volume Forecast, by Pump Type

14.5.8.2. Market Revenue and Volume Forecast, by Reservoir Size

14.5.8.3. Market Revenue and Volume Forecast, by Delivery Mode

14.5.8.4. Market Revenue and Volume Forecast, by End User

14.5.8.5. Market Revenue and Volume Forecast, by Age Group

14.5.8.6. Market Revenue and Volume Forecast, by Distribution Channel

14.5.8.7. Market Revenue and Volume Forecast, by Indication

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Pump Type

14.5.9.2. Market Revenue and Volume Forecast, by Reservoir Size

14.5.9.3. Market Revenue and Volume Forecast, by Delivery Mode

14.5.9.4. Market Revenue and Volume Forecast, by End User

14.5.9.5. Market Revenue and Volume Forecast, by Age Group

14.5.9.6. Market Revenue and Volume Forecast, by Distribution Channel

14.5.9.7. Market Revenue and Volume Forecast, by Indication

Chapter 15. Company Profiles

15.1. Medtronic plc

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Insulet Corporation

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Tandem Diabetes Care Inc.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Roche Diabetes Care

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. SOOIL Development Co., Ltd.

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Debiotech SA

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Beta Bionics

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Ypsomed Holding AG

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Valeritas Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Bigfoot Biomedical

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The implantable insulin pumps market size is expected to increase from USD 5.24 billion in 2024 to USD 14.27 billion by 2034.

The implantable insulin pumps market is expected to grow at a compound annual growth rate (CAGR) of around 10.54% from 2025 to 2034.

The major players in the implantable insulin pumps market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc., Roche Diabetes Care, SOOIL Development Co., Ltd., Debiotech SA, Beta Bionics, Valeritas Inc., Ypsomed Holding AG, CeQur SA, Eli Lilly and Company (Automated Delivery Division), Bigfoot Biomedical, Senseonics Holdings Inc., ViaCyte Inc., Dompe Farmaceutici SpA, Terumo Corporation, Delfu Medical, Eoflow Co., Ltd, and Rani Therapeutics.

The driving factors of the implantable insulin pumps market are the increasing prevalence of diabetes and the demand for precise continuous insulin delivery. Advancements in drug delivery systems and a growing preference for minimally invasive procedures and long-term treatment options are likely to contribute to market growth.

North America region will lead the global implantable insulin pumps market during the forecast period 2025 to 2034.